Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience-Reference-Cited by-同舟云学术

Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience

Published:2023-05-29 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Gargiulo Luigi¹²,Ibba Luciano¹²,Vignoli Carlo Alberto¹²,Facheris Paola¹,Valenti Mario¹²,Costanzo Antonio¹²,Narcisi Alessandra¹

Affiliation:

1. Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy

2. Department of Biomedical Sciences, Humanitas University, Milan, Italy

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2216815

Reference9 articles.

1. Atopic dermatitis: global epidemiology and risk factors;Nutten S.;Ann Nutr Metab,2015

2. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

3. Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study

4. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

5. Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations;Journal of Asthma and Allergy;2024-08

2. Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab;Dermatology Practical & Conceptual;2024-07-31

3. Interleukin antagonists for atopic dermatitis: a new era of therapy;Expert Opinion on Investigational Drugs;2024-06-02

4. Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review;Clinical, Cosmetic and Investigational Dermatology;2024-03

5. Injection site reactions after dupilumab or tralokinumab for atopic dermatitis;Journal of Dermatological Treatment;2024-01-19